- FDA Statement of Identity
- Dietary Supplement
- General Statements: All Other Content
- Highly bioavailable
- Formula re: Contains
- EMIQ 17x Quercetin
- Suggested/Recommended/Usage/Directions
- Suggested use: 1 tablet twice daily.
- Precautions re: Pregnant or Nursing or Prescription Medications
- Note: If you are pregnant, may become pregnant, or breastfeeding, consult your health care professional before using this product.
- Storage
- Store in a cool, dry place.
- Precautions re: All Other
- Do not use if either tamper-evident seal is broken or missing.
- Precautions re: Children
- Keep out of the reach of children.
- Formulation re: Vegetarian/Vegan
- Suitable for Vegetarians.
- Formulation re: Does NOT Contain
- Contains no yeast, dairy, egg, gluten, soy or wheat. Contains no sugar, starch, salt, preservatives, or artificial color, flavor or fragrance.
- Formula re: Contains
- Enzymatically modified isoquercitrin is a type of quercetin that includes additional glucose molecules for increased solubility and bioavailability. This advanced springtime support product offers quick absorption. Enzymatically modified isoquercitrin was demonstrated to have 17 times greater bioavailability than quercetin itself in one clinical trial. Its core compound, quercetin, was shown in preliminary, in-vitro research to inhibit histamine release. Enzymatically modified isoquercitrin administered at the dose supplied in this product has been clinically demonstrated to maintain eye health during periods of seasonal discomfort.
- Brand IP Statement(s) re: (c), (TM), (SM)
- EMIQ is a registered trademark of San-Ei Gen F.F.I., and is used under license from Theravalues Corporation.
- FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- General: Product/Version Code
- SN2685 REV E166